| Molecular dissection of the oncogenic role of ETS1 in the mesenchymal subtypes of head and neck squamous cell carcinoma C Gluck, A Glathar, M Tsompana, N Nowak, LA Garrett-Sinha, MJ Buck, ... PLoS genetics 15 (7), e1008250, 2019 | 29 | 2019 |
| EHF is a novel regulator of cellular redox metabolism and predicts patient prognosis in HNSCC A Oyelakin, KB Nayak, AR Glathar, C Gluck, T Wrynn, A Tugores, ... NAR cancer 4 (2), zcac017, 2022 | 5 | 2022 |
| p63 directs subtype-specific gene expression in HPV+ head and neck squamous cell carcinoma AR Glathar, A Oyelakin, C Gluck, J Bard, S Sinha Frontiers in Oncology 12, 879054, 2022 | 5 | 2022 |
| An integrated genomic approach identifies follistatin as a target of the p63-epidermal growth factor receptor oncogenic network in head and neck squamous cell carcinoma A Oyelakin, J Sosa, KB Nayak, A Glathar, C Gluck, I Sethi, M Tsompana, ... NAR cancer 5 (3), zcad038, 2023 | 1 | 2023 |
| A systemic and integrated analysis of p63-driven regulatory networks in mouse oral squamous cell carcinoma AR Glathar, A Oyelakin, KB Nayak, J Sosa, RA Romano, S Sinha Cancers 15 (2), 446, 2023 | 1 | 2023 |
| Architecture of head and neck squamous cell carcinoma tumor microenvironment revealed: can tertiary lymphoid structures predict post-surgery recurrence? J Sosa, A Glathar, S Sinha Translational Cancer Research, 2024 | | 2024 |
| Abstract A26: Genomic and epigenomic analysis reveal a distinct and targetable transcriptional signature of HNSCC subtypes C Gluck, A Oyelakin, A Glathar, M Buck, RA Romano, S Sinha Clinical Cancer Research 26 (12_Supplement_2), A26-A26, 2020 | | 2020 |
| Genomic and epigenomic analysis reveal a distinct and targetable transcriptional signature of HNSCC subtypes C Gluck, A Oyelakin, A Glathar, M Buck, RA Romano, S Sinha CLINICAL CANCER RESEARCH 26 (12), 42-43, 2020 | | 2020 |
